Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: Completing the subscription for the public offering of warrants (2021-12-30)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 200:The subscription for the public offering of warrants is successfully comleted

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_warrants_offering_results_EN_espi.pdf The subscription for the public offering of warrants is successfully comleted

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 200 / 2021
Date of issue: 2021-12-30
Short name of the issuer
SOPHARMA AD
Subject
The subscription for the public offering of warrants is successfully comleted
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) notifies that the subscription for the public offering of the warrants of the Company has been successfully completed.
The results of the public offering are as follows:

• Closing date of the public offering – 23 December 2021.
• Total number of issued rights – 134 797 899 /one hundred and thirty-four million seven hundred ninety-seven thousand eight hundred ninety-nine/.
• Total number of warrants offered for subscription – BGN 44 932 633 /forty four million nine hundred and thirty two thousand six hundred and thirty three/.
• Total number of warrants subscribed and paid – BGN 44 925 943 /forty four million nine hundred and twenty-five thousand nine hundred and forty-three/.
• Amount received in the account opened at “Raiffeisenbank” (Bulgaria) EAD for the subscribed and paid warrants – BGN 12 579 264.04 /twelve million five hundred and seventy-nine thousand two hundred and sixty-four leva and four stotinki/.
• Amount of all expenses for the public offering – BGN 50 825.45 /fifty thousand eight hundred and twenty five leva and 45 stotinki/.
• During the subscription, the Company and the servicing intermediary did not have any difficulties, disputes and the like in the trading of the rights and the subscription of the warrants, excluding overpayed amounts of BGN 6 137.32 /six thousand one hundred and thirty-seven leva and thirty-two stotinki/ which are due to duplicated payments and will be refunded to the respective persons after the accumulation account has been unblocked.
Annexes
File Description
SFA_warrants_offering_results_EN_espi.pdf
SFA_warrants_offering_results_EN_espi.pdf
The subscription for the public offering of warrants is successfully comleted

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2021-12-30 Ognian Donev Executive Director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 10.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama